Dubai: Under the patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of Dubai Health Authority (DHA), the 25th edition of the Dubai International Pharmaceuticals and Technologies Conference and Exhibition – DUPHAT, the largest pharmaceutical event of its kind in the Middle East North Africa region, will be held from the 25th to the 27th of February, 2020 at the Dubai International Convention and Exhibition Centre.
DUPHAT 2020 comes as the UAE and the wider MENA region is witnessing a huge spike in government spending on healthcare, which is expected to reach 144 billion dollars by the end of 2020, while the MENA regional drug market is projected to be worth 42 billion dollars by 2022. Additionally, the rise in the number of drug manufacturing units, increasing demand for patented and generic drugs owing to the needs of regional population and the ever-growing number of lifestyle diseases such as diabetes, cardiovascular diseases and cancer are driving the growth of the pharma industry in the region.
In its 25th edition, DUPHAT is expected to attract 33,000 visitors and participants from 75 countries including the USA, UK, India and other countries in the MENA region over the 3 days. In addition, the conference is set to witness the participation of 156 speakers who will offer their deep insights during 171 scientific sessions related to the top trending topics in the pharmaceutical industry. Moreover, the pharma event will include 840 poster presentations and 22 workshops to discuss the latest scientific research in pharmacy and also improve the awareness and understanding of the latest trends in the pharma industry.
This year, DUPHAT will also feature important discussions on a range of topics such as ‘Advances in Pharmacy Practice’, ‘Pharmaceutical Innovation’, ‘Next Gen Pharmacist’, ‘Management & Continuity of Pharmaceutical Care’, ‘Pharmacogenomics’, ‘Pharmacoepidemiology Perspectives’ and ‘Leadership & Critical Roles for Pharmacists’ to name a few. In addition, the conference agenda will include dedicated discussions under ‘Kuwait Scientific Program’, ‘Oman Scientific Program’ and ‘Saudi Scientific Program’ while ‘Supply Chain Program’ will feature topics specifically related to the pharmaceutical supply chain.
On the sidelines of DUPHAT 2020, a special conference will be held under the title ‘Regulatory & Manufacturing of the Pharma Sector Value Supply Chain’ addressing a number of topics such as ‘Digital Transformation of Manufacturing Processes for an ultimate paperless manufacturing’, ‘Patient Services and Patient Support Beyond a Job’ and ‘How to Build Patients Trust from a Media Perspective’ among other topics.
Meanwhile, DUPHAT conference attendees will get a chance to receive 32.25 CME credit points accredited by the Dubai Health Authority (DHA) and 22 CME points from The Society of Hospital Pharmacists of Australia (SHPA). In addition, attendees can also avail an opportunity to interact with the top pharmaceutical experts and learn about the future trends in the pharma market.
In its 2020 edition, DUPHAT exhibition occupying an overall space of 25,200 square meters features the presence of 790 participating brands as well as leading pharma and technology brands from the region and across the globe, who will showcase the latest pharmaceutical products, tools and services from their respective countries. In addition, exhibitors get a chance to explore networking, collaboration and business expansion opportunities within the most lucrative markets of the regional pharma market.
On the sidelines of the exhibition, DUPHAT OTC will provide pharma companies a unique opportunity to showcase Over-The-Counter (OTC) Products, highlighting the untapped potential of the OTC consumer health products, which is a booming global market for pharma companies.
Moreover, considering the ever-rising demand to invest in the MENA drug market, DUPHAT -Tech provides a dedicated platform for the best upstream and midstream pharmaceutical manufacturers from Research and Development, Processing and Packaging Machineries, Quality Control, Medical Coding, Labeling, Storage and Logistics, who will showcase the latest in the entire pharma manufacturing supply chain.
Moreover, the DUPHAT Hosted Buyers Program ‘Pharma Business Hub’ being held on the sidelines of DUPHAT exhibition is a dedicated annual networking platform introduced to encourage leading decision makers, potential buyers including the suppliers and manufacturers of the pharma sector to schedule One-to-One B2B Meetings with DUPHAT exhibitors and explore future business collaboration opportunities in the flourishing pharma market in the region.
DUPHAT is organized annually by INDEX Conferences and Exhibitions – a member of INDEX Holding in strategic partnership with General Directorate of Residency and Foreigners Affairs (GDRFA), Dubai Health Authority (DHA), American Society of Health-System Pharmacists, International Society for Pharmacoepidemiology, European Federation for Pharmaceutical Sciences and European Society of Clinical Pharmacy.
-Ends –
© Press Release 2020Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
